Levomilnacipran

Levomilnacipran is a selective serotonin-norepinephrine reuptake inhibitor (SNRI) used for the treatment of depression. It works by inhibiting the reuptake of serotonin and norepinephrine, which increases the availability of these neurotransmitters in the synaptic cleft. The substance has a moderate side effect profile and is frequently prescribed for major depression. Due to its pharmacological properties, it may have effects on the central nervous system and the cardiovascular system.